Verastem (VSTM) Amortizatization of Intangibles (2014 - 2026)

Verastem (VSTM) recorded quarterly Amortizatization of Intangibles of $279000.0 in Q1 2026, little changed quarter-over-quarter from $280000.0 in Q4 2025.

Verastem (VSTM) Amortizatization of Intangibles (2014 - 2026) Analysis & Trends

Verastem's Amortizatization of Intangibles history runs 9 years deep, the most recent figure standing at $279000.0 for Q1 2026.

  • In Q1 2026, Amortizatization of Intangibles changed N/A year-over-year to $279000.0; the TTM figure through Mar 2026 stood at $849000.0 (changed N/A YoY), while the FY2025 annual figure was $698000.0, changed N/A from the prior year.
  • Amortizatization of Intangibles was $279000.0 for Q1 2026 at Verastem, roughly flat from $280000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $290000.0 in Q3 2025 to a low of $279000.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 13,267.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Verastem 407.42 Mn 225.74 Mn 15.90 Mn 279,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 279,000.00
Mar 31, 2026 279,000.00
Dec 31, 2025 280,000.00
Dec 31, 2025 280,000.00
Sep 30, 2025 290,000.00
Sep 30, 2025 290,000.00
Sep 30, 2020 100,000.00
Sep 30, 2020 100,000.00
Jun 30, 2020 400,000.00
Jun 30, 2020 400,000.00
Mar 31, 2020 392,000.00
Mar 31, 2020 392,000.00
Dec 31, 2019 392,000.00
Dec 31, 2019 392,000.00
Sep 30, 2019 400,000.00
Sep 30, 2019 400,000.00
Jun 30, 2019 400,000.00
Jun 30, 2019 400,000.00
Mar 31, 2019 392,000.00
Mar 31, 2019 392,000.00